CVS Group plc, a leading provider of integrated veterinary services in the UK, has applied for the admission of 410,000 of its ordinary shares to trading on AIM. These shares will be reserved under block listings, with 350,000 shares to be added to the existing CVS Group SAYE Plan block listing and 60,000 shares to be added to the CVS Long Term Incentive Plan block listing. The shares will be issued in connection with the exercise of option awards and the grant, vesting, and/or exercise of awards under the respective plans. The block-listed shares are expected to be admitted on 28 December 2023.
CVS Group operates c.500 veterinary practices across the UK, Australia, the Netherlands, and the Republic of Ireland. The company is focused on providing high-quality clinical services to its clients and their animals, with dedicated clinical teams and support colleagues at the core of its strategy. In addition to veterinary practices, CVS also operates laboratories, crematoria, buying groups, and an online retail business called Animed Direct.
No further information was provided in the news release.